Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy
{{output}}
Aberrant glycosylation recently emerged as an unmissable hallmark of cancer progression in many cancers. In melanoma, there is growing evidence that the tumour 'glycocode' plays a major role in promoting cell proliferation, invasion, migration, but also dictat... ...
